Excellent Support for Your Practice and Your Patients

Dedicated office support for common concerns

An ENBREL Access Specialist can provide dedicated and timely assistance with:

  • Insurance Verifications
  • Prior Authorizations
  • Appeals
  • Support for uninsured, underinsured, unemployed, and Medicare patients

Easy and timely assistance for patients

For all eligible patients,* ENBREL Support™ may offer:

  • 6 months at no out-of-pocket cost for patients
  • $10 or less out-of-pocket cost per month thereafter
  • Support for ENBREL co-pay or co-insurance, and prescription deductible

Program provides up to $4,000 of assistance per patient for each 6-month period. Patient is responsible for costs above these amounts.

Patients can visit EnbrelSupport.com to get started or call 1-888-4ENBREL (1-888-436-2735).

 *Eligibility: Open to patients with commercial prescription insurance. Not open to uninsured patients or patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare including Medicare Part D, Medicaid, etc.) or patients who live in Massachusetts (or where prohibited by law). Restrictions, including monthly maximums, may apply. Offer subject to change or discontinuation without notice.

 Each time patients fill their ENBREL prescription, they will receive 50% off their out-of-pocket costs or pay no more than $10 per month—whichever helps them more.

Additional Resources for Patients

  • Registered nurses available 8 AM to 11 PM (ET), 7 days a week, to answer any questions patients may have about ENBREL treatment
  • Personalized help from insurance specialists who are ready to help answer questions about coverage Monday through Friday, 8 AM to 8 PM (ET)
  • Live support available in over 200 languages
  • Sharps containers for safe disposal of ENBREL injection materials
  • A travel pack so patients can take ENBREL wherever they go
Important Safety Information Prescribing Information Medication Guide
Indications
 
Safety Information ISI

ENBREL is
efficacious across three measures

In patients with moderate to severe early RA, ENBREL has shown clinical, structural, and functional efficacy.

View functional efficacy in RA

Are you a primary care physician?

Help limit the progression of your patient's joint damage by working with a rheumatologist to provide an appropriate treatment plan.

Find a rheumatologist
ENBREL Support (TM) helped Darla with her ENBREL prescription co-pay.
Darla R., ENBREL RA patient since 2000
 
 
Close
You are leaving Enbrel.com/RheumPro
Please know that Amgen and Pfizer do not endorse and are not responsible for the content included on the site you are about to enter. Click the "Continue" button to proceed.

To return to ENBREL.com, click "Cancel" or close this window.

Privacy Policy  Terms of Use
This site is intended for US Audiences only.
©2011 Amgen, Inc., Thousand Oaks, CA 91320 and Pfizer Inc
Close
E-mail this page to a colleague
Please correct the fields marked in red
Send
This content is for US health care professionals only. Amgen and Pfizer will not use your e-mail address or your colleague's e-mail address for any other purpose. To learn more about our use of your information and your rights, please consult our Privacy Policy.
Close

Send another e-mail
Return to enbrel.com/RheumPro

Close
Notice

The following information is intended for use only by residents of the United States. Countries outside of the United States may have regulatory requirements or medical practices that are different than those in the United States and may require reference to different or additional information. Therefore, this information may not be appropriate outside of the United States.

If you are a resident of the United States or one of its territories, or a health care professional practicing your profession in the United States or one of its territories, please click below.

If you are a resident of a country other than the United States, please visit the Pfizer website and the Amgen website to find information about our offices around the globe.
Close
Disease activity vs. structural progression in RA